Deere upgraded, Lumentum initiated: Wall Street's top analyst calls

Analysts upgraded Deere (DE) to Outperform with a $800 target, citing strong North American demand. Abercrombie & Fitch (ANF) was upgraded to Buy with a $162 target after Q2 earnings beat. Agco (AGCO) upgraded to Outperform with a $150 target, expecting 2027 volume recovery. Kaiser Aluminum (KALU) upgraded to Buy with a $184 target. Stag Industrial (STAG) upgraded to Outperform. PG&E (PCG) downgraded by Wells Fargo and BMO. Mizuho downgraded PG&E, Sempra Energy (SRE), and Edison International (E

Original reporting
Published Aug 31, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 3:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Deere upgraded, Lumentum initiated: Wall Street's top analyst calls — source image
Decision brief

The 30-second read

$DEBullishLow
01

Why it matters

The mixed set of rating changes provides modest trading signals, mainly for short‑term positioning rather than long‑term conviction.

02

Market read

Rating changes affect individual stock outlooks but do not constitute a market‑wide catalyst.

03

What to watch

Potential impact of upcoming regulatory changes on utilities and biotech trial timelines not fully priced yet.

Relevance 5/10Novelty 4/10Timing: today

Background

Analyst firms released a series of upgrades, downgrades, and new coverage notes across multiple sectors.

Company-level read

Ticker impact

$DEBullishMedium confidence
Context

Baird upgraded Deere to Outperform with a $800 price target.

Expected impact

Modest upside if market follows upgrade.

Evidence & confidence

Upgrade signals improved outlook; price may rise toward target.

$ANFBullishMedium confidence
Context

Argus upgraded Abercrombie & Fitch to Buy with a $162 price target after Q2 earnings beat.

Expected impact

Potential short-term rally.

Evidence & confidence

Earnings beat and higher target may attract buyers.

$AGCOBullishMedium confidence
Context

Baird upgraded Agco to Outperform with a $150 price target.

Expected impact

Modest upside.

Evidence & confidence

Analyst expects 2027 volume boost to lift earnings.

$KALUBullishMedium confidence
Context

UBS upgraded Kaiser Aluminum to Buy with a $184 price target.

Expected impact

Potential upside.

Evidence & confidence

Analyst sees entry point after recent sell‑off.

$STAGBullishLow confidence
Context

Baird upgraded Stag Industrial to Outperform, keeping $42 target.

Expected impact

Limited upside.

Evidence & confidence

Valuation appeal may draw interest.

$PCGBearishMedium confidence
Context

Wells Fargo downgraded PG&E to Equal Weight and BMO Capital to Market Perform.

Expected impact

Potential downside.

Evidence & confidence

Regulatory risk lowers outlook.

$SREBearishMedium confidence
Context

Mizuho downgraded Sempra Energy to Neutral from Outperform.

Expected impact

Potential downside.

Evidence & confidence

Legislative inaction hurts outlook.

$EIXBearishMedium confidence
Context

Mizuho downgraded Edison International to Neutral from Outperform.

Expected impact

Potential downside.

Evidence & confidence

Similar concerns as other California utilities.

Market effects

Broad upgrades/downgrades may shift sentiment in industrials, consumer discretionary, and biotech sectors.

U.S. equities may see modest rebalancing as analysts adjust targets.

Limited; primarily U.S. listed companies.

Counterpoint

Some upgrades may be premature given macro headwinds; investors could wait for earnings confirmation.

Key entities

  • Baird

    Issued upgrades for Deere, Agco, and Stag Industrial.

  • UBS

    Upgraded Kaiser Aluminum.

  • Wells Fargo

    Downgraded PG&E.

  • Evercore ISI

    Initiated coverage of Lumentum.

Related articles

$SREMed

Sempra (SRE) Raises Oncor Five Year Capital Plan 20%

Sempra (SRE) announced a 20% increase in Oncor's five-year capital plan due to strong electricity demand in Texas. The company also plans to sell a 45% stake in Sempra Infrastructure Partners to KKR. Sempra, with a market cap of $51.1b, focuses on grid and energy infrastructure in the U.S. and Mexico. The capital plan uplift and sale align with Sempra's long-term Texas grid expansion and capital recycling strategy.

$SCTXMedAI 9/10

One Shot, Two Years of Lower Cholesterol: Scribe’s CRISPR Gene Therapy Begins Human Trials

Scribe Therapeutics (SCTX) presented data at AHA 2026 showing its gene therapy STX-1150 maintained LDL cholesterol control for two years in non-human primates. The therapy uses epigenetic gene silencing to target PCSK9. Separately, Scribe's STX-1200, a CRISPR-based LPA gene editor, showed durable Lp(a) reduction in preclinical models. Novartis' pelacarsen failed to reduce cardiovascular events in a Phase 3 trial, impacting competitors.

$PCGMed

PG&E Undergrounding Plan May Shrink Under CPUC Proposal

California regulators may reduce PG&E's plan to bury 5,000 miles of power lines to 1,100 miles, pending a November 19 vote. PG&E argues undergrounding reduces wildfire risk by 98% and is cost-effective long-term, with the project costing $16 billion and adding $9/month to customer bills, according to the company.

$SREMed

Sempra Energy Q3 Earnings Call Highlights

Sempra Energy (SRE) guided toward the high end of its 2026 adjusted earnings range of $4.80-$5.30 per share, affirmed 2027 guidance of $5.10-$5.70, and maintained a 7-9% long-term growth rate. A California decision may impact 2027 earnings, but no long-term guidance changes are expected. The company plans to sell a 45% stake in SI Partners to reduce debt and strengthen its balance sheet.

$MRVLHighAI 9/10

Why Marvell Technology Stock Plunged 28.1% This Week

Marvell Technology (MRVL) fell 28.1% this week after announcing a $115 billion all-stock deal to acquire Lumentum (LITE). The acquisition, valued at a significant premium, raised dilution concerns, leading to downgrades from analysts. Marvell's stock is down 57.2% from its 52-week high, and the deal faces regulatory hurdles and potential channel conflicts.

$MRVLHighAI 9/10

Marvell and Western Digital Just Had Their Worst Week Since 2001

Marvell (MRVL) and Western Digital (WDC) each fell 28% in the week ended November 6, 2026, their worst weekly performance since 2001. Both companies had raised guidance in their latest earnings reports. The selloff was driven by election results and broader market reactions to AI data center policies. Marvell also faced deal risk due to its acquisition of Lumentum (LITE). Western Digital appears more resilient post-selloff, with a simpler business and a deeper discount to its record high.